Naproxen Sodium And Diphenhydramine Hcl Tablet, Film Coated
Product Images NDC 62207-814

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Naproxen Sodium And Diphenhydramine Hcl (NDC 62207-814). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton

This is a drug information sheet, providing information on a medication including dosage, active and inactive ingredients, possible side effects, and warnings. There is a phone number for questions or comments.*

FDA Label Image

Label

FDA Label Image

Nap-diphen-label1-jpg (Nap Diphen Label1 Jpg)

FDA Label Image

Nap-diphen-label2-jpg (Nap Diphen Label2 Jpg)

This is a description of Naproxen Sodium and Diphenhydramine Hydrochloride tablets, which contain 220mg of Naproxen Sodium USP and 25mg of Diphenhydramine Hydrochloride USP. The batch contains 7500 tablets with a manufacturing date (Mfg. Dt.) and expiration date (Exp.DL.), as well as a manufacturing license number (Mfg.Lic.No.). The NDC No. is 62207-814-39, and the storage temperature should be between 20°C to 25°C (68°F to 77°F). The tablets are made in India, with the FG code: 700000002498. The caution is for repacking only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.